Cargando…

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer

Enhancer of zeste homolog2 (EZH2) is the histone lysine N-methyltransferase component of the Polycomb repressive complex 2 (PRC2), which in conjunction with embryonic ectoderm development (EED) and suppressor of zeste 12 homolog (SUZ12), regulates cell lineage determination and homeostasis. Enzymati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Woojin, Bird, Gregory H., Neff, Tobias, Guo, Guoji, Kerenyi, Marc A., Walensky, Loren D., Orkin, Stuart H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778130/ https://www.ncbi.nlm.nih.gov/pubmed/23974116 http://dx.doi.org/10.1038/nchembio.1331

Ejemplares similares

Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer
por: Chen, Huiming, et al.
Publicado: (2015)

Polycomb Repressive Complex 2 Modulation through the Development of EZH2–EED Interaction Inhibitors and EED Binders
por: Tomassi, Stefano, et al.
Publicado: (2021)

Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
por: Li, Xin, et al.
Publicado: (2021)

PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ
por: Yu, Hongxiang, et al.
Publicado: (2012)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia
por: Danis, Etienne, et al.
Publicado: (2016)

Pharmacological inhibition of EZH2 disrupts the female germline epigenome
por: Prokopuk, Lexie, et al.
Publicado: (2018)

Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma
por: Cho, Yong Jin, et al.
Publicado: (2018)

Regulation of haematopoietic multipotency by EZH1
por: Vo, Linda T., et al.
Publicado: (2018)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Tazemetostat: EZH2 Inhibitor
por: Straining, Rachael, et al.
Publicado: (2022)

Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression
por: Grzenda, Adrienne, et al.
Publicado: (2013)

Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors
por: Gibaja, V, et al.
Publicado: (2016)

EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Lui, Julian C., et al.
Publicado: (2016)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

An EZH2‐dependent transcriptional complex promotes aberrant epithelial remodelling after injury
por: Le, Huy Q, et al.
Publicado: (2021)

The role of EZH2 in tumour progression
por: Chang, C-J, et al.
Publicado: (2012)

Regulation and Role of EZH2 in Cancer
por: Yamaguchi, Hirohito, et al.
Publicado: (2014)

The noncanonical role of EZH2 in cancer
por: Huang, Jinhua, et al.
Publicado: (2021)

EZH2: An Accomplice of Gastric Cancer
por: Yu, Wuhan, et al.
Publicado: (2023)

SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters
por: Groß, Elisabeth, et al.
Publicado: (2023)

Loss of BAP1 function leads to EZH2-dependent transformation
por: LaFave, Lindsay M., et al.
Publicado: (2015)

Ezh1 arises from Ezh2 gene duplication but its function is not required for zebrafish development
por: Völkel, Pamela, et al.
Publicado: (2019)

Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2
por: Lau-Corona, Dana, et al.
Publicado: (2020)

Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
por: Stojic, Lovorka, et al.
Publicado: (2011)

Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)

Post-translational modifications of EZH2 in cancer
por: Li, Zhongwei, et al.
Publicado: (2020)

Role of EZH2 in Uterine Gland Development
por: Ni, Nan, et al.
Publicado: (2022)

Non-canonical functions of EZH2 in cancer
por: Zimmerman, Sarah M., et al.
Publicado: (2023)

The roles of EZH2 in cancer and its inhibitors
por: Liu, Yuankai, et al.
Publicado: (2023)

Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis
por: Shimizu, Takafumi, et al.
Publicado: (2016)

Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors
por: Baker, Theresa, et al.
Publicado: (2015)

Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
por: Honma, Daisuke, et al.
Publicado: (2017)

Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma
por: Wang, Yingyi, et al.
Publicado: (2016)

Disruption of FOXP3–EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation
por: Bamidele, Adebowale O., et al.
Publicado: (2018)

Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome
por: Aoyama, Kazumasa, et al.
Publicado: (2018)

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
por: Sun, Si, et al.
Publicado: (2020)

The Regulatory Roles of Ezh2 in Response to Lipopolysaccharide (LPS) in Macrophages and Mice with Conditional Ezh2 Deletion with LysM-Cre System
por: Kunanopparat, Areerat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0q39f26nkhstg7q46u3kibf7s7